This rather broad definition has been shown to be incomplete as potentially highly relevant circulating cancer-associated cells might lack EpCAM, or even co-express CD45 and other macrophage/myeloid or stem-cell markers [4,5,6,7,8] (Table 1). Here, PTPRC is linked to cancer.